Russian corona vaccine passes early trials

2 October, 2020 12:00 AM printer

Russian corona vaccine passes early trials

Early clinical trials of a second Russian coronavirus vaccine have proved successful, its developer said Thursday after Russia boasted of approving the world’s first vaccine, reports AFP.

Russia’s Vektor—a top-secret state virology research centre in Siberia—said that early-stage trials were successful for its own experimental vaccine, named EpiVacCorona. “The first two phases of clinical trials demonstrated the effectiveness and safety of the EpiVacCorona vaccine,” Vektor’s press department told the Interfax news agency.     

Russia announced in August that it had developed the world’s first registered vaccine—named “Sputnik V” after the world’s first satellite.

It raised concerns among Western scientists by announcing that the vaccine—developed by Moscow’s Gamaleya research centre—had received approval before full clinical trials have been completed.